Clinical trials
Rhabdomyosarcoma trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 2 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
| Active, not recruiting | 5 |
| Recruiting | 3 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 10 |
| Children's Oncology Group | 9 |
| European Organisation for Research and Treatment of Cancer - EORTC | 2 |
| Novartis Pharmaceuticals | 2 |
| Boehringer Ingelheim | 1 |
| Celgene | 1 |
| Cellectar Biosciences, Inc. | 1 |
| Eisai Inc. | 1 |
| Milton S. Hershey Medical Center | 1 |
| NCIC Clinical Trials Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rhabdomyosarcoma | 32 |
| Sarcoma | 21 |
| Neuroblastoma | 13 |
| Osteosarcoma | 10 |
| Sarcoma, Ewing | 8 |
| Fibrosarcoma | 6 |
| Liposarcoma | 6 |
| Medulloblastoma | 6 |
| Neuroectodermal Tumors, Primitive, Peripheral | 6 |
| Rhabdoid Tumor | 6 |
Trials
Showing 26 to 32 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.